U.S. flag

An official website of the United States government, Department of Justice.

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Program

Award Information

Award #
2015-PM-BX-0003
Location
Congressional District
Status
Closed
Funding First Awarded
2015
Total funding (to date)
$409,949

Description of original award (Fiscal Year 2015, $409,949)

The Harold Rogers Prescription Drug Monitoring Program (PDMP) provides funding to allow state’s discretion to plan, implement, or enhance a PDMP to accommodate local decision-making based on state laws and preferences, while encouraging the replication of promising practices. In FY 2015, the PDMP Program provides resources in four purpose areas to support the following: 1) statewide implementation and enhancement grants; 2) practitioner and research partnership cooperative agreements; 3) data-driven multi-disciplinary approaches to reducing prescription abuse cooperative agreements; and 4) tribal prescription drug monitoring data sharing grants.

The Pennsylvania Department of Health will use the grant funds to focus on the program’s main goals. The main goals are to establish and build a data collection and analysis system; develop an infrastructure to support programmatic activities; facilitate the exchange of information and collected prescription data and other scheduled chemical products among states; facilitate the establishment of collaborations; develop a training program for system users; produce and disseminate educational materials; and assess the efficiency and effectiveness of the program. Funds may also be used to enhance the functioning of a data collection and analysis system; enhance an existing educational or training program; support collaborations with law enforcement and prosecutors or public health officials; support collaborations with treatment providers and drug courts; facilitate electronic information sharing among states in compliance with the National PMIX Architecture; expand monitoring to Schedules II, III, IV, and V; develop or enhance the capacity to provide unsolicited reports of controlled substance prescribing to authorized individuals or entities; and assess the efficiency and effectiveness of the program.
CA/NCF

Date Created: September 17, 2015